These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 27028715

  • 1. Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice.
    Peng J, Hui K, Hao C, Peng Z, Gao QX, Jin Q, Lei G, Min J, Qi Z, Bo C, Dong QN, Bing ZH, Jia XY, Fu DL.
    Connect Tissue Res; 2016 Jul; 57(4):277-89. PubMed ID: 27028715
    [Abstract] [Full Text] [Related]

  • 2. Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice.
    Coe LM, Zhang J, McCabe LR.
    J Cell Physiol; 2013 Apr; 228(4):689-95. PubMed ID: 22886636
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice.
    Hu XF, Xiang G, Wang TJ, Ma YB, Zhang Y, Yan YB, Zhao X, Wu ZX, Feng YF, Lei W.
    Theranostics; 2021 Apr; 11(8):3796-3812. PubMed ID: 33664862
    [Abstract] [Full Text] [Related]

  • 5. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.
    Iyer S, Han L, Ambrogini E, Yavropoulou M, Fowlkes J, Manolagas SC, Almeida M.
    J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Methoxsalen and Bergapten Prevent Diabetes-Induced Osteoporosis by the Suppression of Osteoclastogenic Gene Expression in Mice.
    Ham JR, Choi RY, Lee HI, Lee MK.
    Int J Mol Sci; 2019 Mar 14; 20(6):. PubMed ID: 30875838
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K.
    Osteoporos Int; 2016 Apr 14; 27(4):1631-1643. PubMed ID: 26588909
    [Abstract] [Full Text] [Related]

  • 11. TLR4 knockout ameliorates streptozotocin-induced osteoporosis in a mouse model of diabetes.
    Cao Y, Han X, Wang Z, Liu Y, Wang Y, Zhang R, Ye J, Zou L, Dai W.
    Biochem Biophys Res Commun; 2021 Mar 26; 546():185-191. PubMed ID: 33601314
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
    Motyl KJ, Raetz M, Tekalur SA, Schwartz RC, McCabe LR.
    Am J Physiol Regul Integr Comp Physiol; 2011 May 26; 300(5):R1250-60. PubMed ID: 21346244
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss.
    Zhao Q, Shen X, Zhang W, Zhu G, Qi J, Deng L.
    Bone; 2012 Mar 26; 50(3):763-70. PubMed ID: 22193550
    [Abstract] [Full Text] [Related]

  • 16. High fat diet attenuates hyperglycemia, body composition changes, and bone loss in male streptozotocin-induced type 1 diabetic mice.
    Carvalho AL, DeMambro VE, Guntur AR, Le P, Nagano K, Baron R, de Paula FJA, Motyl KJ.
    J Cell Physiol; 2018 Feb 26; 233(2):1585-1600. PubMed ID: 28631813
    [Abstract] [Full Text] [Related]

  • 17. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
    Kalaitzoglou E, Popescu I, Bunn RC, Fowlkes JL, Thrailkill KM.
    Curr Osteoporos Rep; 2016 Dec 26; 14(6):310-319. PubMed ID: 27704393
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.
    Baud'huin M, Solban N, Cornwall-Brady M, Sako D, Kawamoto Y, Liharska K, Lath D, Bouxsein ML, Underwood KW, Ucran J, Kumar R, Pobre E, Grinberg A, Seehra J, Canalis E, Pearsall RS, Croucher PI.
    Proc Natl Acad Sci U S A; 2012 Jul 24; 109(30):12207-12. PubMed ID: 22761317
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.